Bank of America
KYNB

Bank of America’s Kyntra Bio KYNB Stock Holding History

Bank of America’s Portfolio KYNB Stock Details KYNB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-11,492
Closed -$776K – 7821
2023
Q2 		$776K Buy
+11,492
New +$4.75M ﹤0.01% 4958
2021
Q1 		– Sell
-288
Closed -$267K – 7523
2020
Q4 		$267K Hold
288
– – ﹤0.01% 5408
2020
Q3 		$296K Hold
288
– – ﹤0.01% 5062
2020
Q2 		$292K Sell
288
-160
-36% -$149K ﹤0.01% 4994
2020
Q1 		$389K Buy
+448
New +$445K ﹤0.01% 4683
2019
Q1 		– Sell
-2,848
Closed -$3.29M – 7194
2018
Q4 		$3.29M Buy
+2,848
New +$3.2M ﹤0.01% 3412

Other funds holding KYNB

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $103B AUM 28.65% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM

Bank of America's KYNB Position: Q1 2026 in Review

Bank of America sold out of Kyntra Bio (KYNB) in Q1 2026, closing a stake of 595 shares — an estimated $5.22K sold.

Bank of America first reported a position in KYNB in Q4 2014 and held it in 45 quarters. The position peaked at $23M in Q1 2019. 32 funds tracked by Wall St. Rank hold KYNB as of Q1 2026.

  • Bank of America reported no remaining Kyntra Bio position as of Q1 2026 after selling out during the quarter.
  • Bank of America sold 595 Kyntra Bio shares in Q1 2026, an estimated $5.22K.
  • Bank of America first reported a position in Kyntra Bio in Q4 2014 and held it in 45 quarters.
  • Bank of America's Kyntra Bio position peaked at $23M in Q1 2019.
  • 32 funds tracked by Wall St. Rank held Kyntra Bio as of Q1 2026.

Based on Bank of America's 13F filing for Q1 2026, filed 18 May 2026.